Thu, May 19, 2022
Wed, May 18, 2022
Tue, May 17, 2022
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022

Andrew Berens Maintained (AGIO) at Hold with Increased Target to $33 on, May 17th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-33-on-may-17th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Berens of SVB Leerink, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Hold with Increased Target from $30 to $33 on, May 17th, 2022.

Andrew has made no other calls on AGIO in the last 4 months.



There are 4 other peers that have a rating on AGIO. Out of the 4 peers that are also analyzing AGIO, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Andrew


  • Salveen Richter of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $23 on, Monday, March 7th, 2022
  • Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $96 on, Thursday, March 3rd, 2022
  • Kennen MacKay of "RBC Capital" Maintained at Buy with Increased Target to $67 on, Friday, February 25th, 2022
  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $44 on, Wednesday, February 16th, 2022

Publication Contributing Sources